Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Raised by Vertex Planning Partners LLC

Vertex Planning Partners LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 851 shares of the medical equipment provider’s stock after acquiring an additional 30 shares during the period. Vertex Planning Partners LLC’s holdings in Intuitive Surgical were worth $444,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of ISRG. Howard Capital Management Group LLC increased its position in Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after acquiring an additional 92 shares during the period. Principal Financial Group Inc. increased its holdings in shares of Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after purchasing an additional 9,194 shares during the period. Quest Partners LLC bought a new stake in shares of Intuitive Surgical during the third quarter valued at about $173,000. Algert Global LLC acquired a new stake in Intuitive Surgical in the third quarter worth about $1,988,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Intuitive Surgical in the 3rd quarter valued at about $559,000. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 0.2 %

Intuitive Surgical stock opened at $507.90 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company’s fifty day simple moving average is $558.29 and its 200-day simple moving average is $532.25. The stock has a market cap of $180.90 billion, a P/E ratio of 79.24, a P/E/G ratio of 5.85 and a beta of 1.43.

Analyst Ratings Changes

ISRG has been the subject of a number of research analyst reports. Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Stifel Nicolaus upped their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Robert W. Baird decreased their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, Raymond James raised their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.